These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30025770)

  • 21. Student pharmacists' attitudes, perceptions, and knowledge regarding opioid use, misuse, and overdose: Four years of data.
    Murnane KS; Augustine JM; Marshall LL
    Curr Pharm Teach Learn; 2022 Oct; 14(10):1222-1228. PubMed ID: 36283793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dispensing Naloxone Without a Prescription: Survey Evaluation of Ohio Pharmacists.
    Thompson EL; Rao PSS; Hayes C; Purtill C
    J Pharm Pract; 2019 Aug; 32(4):412-421. PubMed ID: 29478362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.
    Green TC; Dauria EF; Bratberg J; Davis CS; Walley AY
    Harm Reduct J; 2015 Aug; 12():25. PubMed ID: 26245865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction.
    Mahon LR; Hawthorne AN; Lee J; Blue H; Palombi L
    Harm Reduct J; 2018 Nov; 15(1):57. PubMed ID: 30445958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone Counseling for Harm Reduction and Patient Engagement.
    Han JK; Hill LG; Koenig ME; Das N
    Fam Med; 2017 Oct; 49(9):730-733. PubMed ID: 29045991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of mandatory alerts on long-acting opioid prescriptions and the use of a community pharmacy naloxone protocol.
    Coffman R; Johnson A; Frede S; Pleiman M; Johnson K
    J Am Pharm Assoc (2003); 2022; 62(4S):S35-S40.e1. PubMed ID: 34930681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention.
    Eukel HN; Skoy E; Werremeyer A; Burck S; Strand M
    J Contin Educ Health Prof; 2019; 39(1):7-12. PubMed ID: 30614959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate use disorders and overdose: Medical students' experiences, satisfaction with learning, and attitudes toward community naloxone provision.
    Tobin H; Klimas J; Barry T; Egan M; Bury G
    Addict Behav; 2018 Nov; 86():61-65. PubMed ID: 29198489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
    Melaragni F; Levy C; Pedrazzi J; Andersen M
    J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study.
    Burstein D; Baird J; Bratberg J; Donovan E; Soipe A; Tapper A; Case P; Walley AY; Green TC
    J Am Pharm Assoc (2003); 2020; 60(2):304-310. PubMed ID: 31870862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach.
    Varisco TJ; Downs CG; Rathburn KR; Fleming ML; Thornton JD
    Int J Drug Policy; 2020 Sep; 83():102827. PubMed ID: 32589581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
    Roberts AW; Carpenter DM; Smith A; Look KA
    Res Social Adm Pharm; 2019 Feb; 15(2):222-225. PubMed ID: 29650444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacy on-site overdose protocols and prevention of overdose.
    Green TC; Soipe A; Baloy B; Burstein D; Xuan Z; Tapper A; Walley AY; Case P; Bratberg J; Baird J
    Subst Abus; 2022; 43(1):64-68. PubMed ID: 32186478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates.
    Gangal NS; Hincapie AL; Jandarov R; Frede SM; Boone JM; MacKinnon NJ; Koechlin K; DeFiore-Hyrmer J; Holthusen A; Heaton PC
    JAMA Netw Open; 2020 Jan; 3(1):e1920310. PubMed ID: 32003819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Opioid Education Program for Baccalaureate Nursing Students.
    Hines CB; Cody SL; Eyer JC; Coupe L
    J Addict Nurs; 2021 Apr-Jun 01; 32(2):88-94. PubMed ID: 34060759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incoming medical students' knowledge of and attitudes toward people with substance use disorders: Implications for curricular training.
    Moses TE; Chammaa M; Ramos R; Waineo E; Greenwald MK
    Subst Abus; 2021; 42(4):692-698. PubMed ID: 33166242
    [No Abstract]   [Full Text] [Related]  

  • 39. Implementing an overdose education and naloxone distribution program in a health system.
    Devries J; Rafie S; Polston G
    J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding naloxone education in the doctor of pharmacy curriculum.
    Musco S; Kicklighter J; Arnett A
    Curr Pharm Teach Learn; 2022 Mar; 14(3):310-317. PubMed ID: 35307090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.